日期 | 题目 | 杂志名称 | 汇报人 | |
1 | 2021-03-17 | Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8 cells | Nature | 陈 玲 |
2 | 2021-03-24 | In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma. | Immunity | 胡 莉 |
3 | 2021-03-31 | Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer | Cell | 李莉君 |
4 | 2021-04-07 | Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. | Cell | 王 阳 |
5 | 2021-04-14 | A burned-out CD8+ T-cell subset expands in the tumor microenvironment and curbs cancer | Cancer Discovery | 何柏霖 |
6 | 2021-04-21 | TGF-β suppresses type 2 immunity to cancer | Nature | 邹玉莲 |
7 | 2021-04-28 | CAR directs T cell adaptation to bile acids in the small intestine | Nature | 侯 平 |
8 | 2021-05-12 | Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice | Nature | 车耀健 |
9 | 2021-05-19 | Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory | Cell | 朱艳阳 |
10 | 2021-05-26 | Interleukin-17D regulates group3 innate lymphoid cell function through its receptor CD93 | Immunity | 王 珺 |
11 | 2021-06-02 | Tumor hypoxia represses γδ T cell-mediated antitumor immunity against brain tumors | Nature Immunology | 王春华 |
12 | 2021-06-16 | Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine | 陈远贵 |
13 | 2021-06-23 | Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion | Cell | 陈 权 |
14 | 2021-07-15 | PD-L1-Mediated Gasdermin C Expression Switches Apoptosis to Pyroptosis in Cancer Cells and Facilitates Tumor Necrosis | Nature Cell Biology | 张明炜 |
15 | 2021-09-15 | Blockade ofthe CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy | Science Translational Medicine | 兰海林 |
16 | 2021-09-22 | Pharmacological activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting anti-tumor immunity | Cancer Discovery | 陈炳坤 |
17 | 2021-09-29 | Intratumoral activation of the necroptotic pathway components PIPK1 and RIPK3 potentiates antitumor immunity | Science Immunology | 马小静 |
18 | 2021-10-06 | Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells | Science | 杨明欢 |
19 | 2021-10-13 | Simultaneous targeting of TGF-b/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion | Cancer Cell | Linda |
20 | 2021-10-20 | Selectively Suppressing Tumor Angiogenesis for Targeted Breast Cancer Therapy by Genetically Engineered Phage | Advanced materials | 张仁璐 |
21 | 2021-10-27 | Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis | Cancer Discovery | 朱艳阳 |
22 | 2021-11-03 | ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis | Cancer Cell | 沈 敏 |
23 | 2021-11-17 | Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling | Science | 咸 娜 |
24 | 2021-12-01 | Microenvironment mapping via Dexter energy transfer on immune cells | Science | 康俊彪 |
25 | 2021-12-08 | Targeted antibody and cytokine cancer immunotherapies through collagen affinity | Science Translational Medicine | 吴琼雯 |
